Angiotensin-Receptor Blockers, Type 2 Diabetes, and Renoprotection
- 28 February 2002
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (9), 705-707
- https://doi.org/10.1056/nejm200202283460912
Abstract
I am surprised that the target systolic blood pressures in three studies of the renoprotective effects of angiotensin-receptor blockers in patients with type 2 diabetes (Sept. 20 issue)1-3 exceeded the threshold of less than 130 mm Hg recommended in the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI).4 After treatment, the mean systolic blood pressure for all treatment groups in each study was 140 mm Hg or higher. What kind of example is this for practicing physicians who treat hypertensive patients with diabetes?Keywords
This publication has 13 references indexed in Scilit:
- Are ACE Inhibitors a “Magic Bullet” Against Oxidative Stress?Circulation, 2001
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive RatsCirculation, 2001
- Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.Diabetes, 2000
- Predictors of the Development of Hyperkalemia in Patients Using Angiotensin-Converting Enzyme InhibitorsAmerican Journal of Nephrology, 2000
- Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidasesCardiovascular Research, 1999
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of Internal Medicine, 1997
- Oxidative Stress and Diabetic Vascular ComplicationsDiabetes Care, 1996